Home › Essential Thrombocythemia › Kansas
Pag-aaral pangklinika para sa Essential Thrombocythemia sa Kansas
3 pag-aaral para sa Essential Thrombocythemia ang naghahanap ng mga kalahok sa mga site sa Kansas.
Opisyal na teksto ng pag-aaral (English)
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
- University of Kansas Clinical Research Center, Fairway
- University of Kansas Cancer Center, Kansas City
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- at 1 pa
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06661915A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
- The University of Kansas Cancer Center, Westwood
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07623200A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
- The University of Kansas Cancer Center, Westwood
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 17, 2026 · NCT06034002Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.